24230G}1995PLC024288 Date: 11% February, 2016 LPL LINCOLN To The Department of Corporate Service, Bombay Stock Exchange Limited, Phiroze Jeejeebhoy Tower, Dalal Street, ‘Mumbai - 400 001. Dear Sir, ‘SUB OUTCOME OF BOARD MEETING. ‘With reference to the above, we would like to inform that the Board of Directors ofthe Company at their ‘meeting held on Thursday 11° February, 2016 have considered and approved the following: 1, Adoption of "Uniform Listing Agreement” as required to be entered by listed entity as per Regulation 109 of SEBI (Issue of Capital and Disclosure Requirements) Regulation, 2009 read with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with the Stock Exchange. (Ref. SEBI Circular No, CIR/CFD/CMD/6/2015 dated 13th October, 2015.) 2. Polley for determining materiality of events as required under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. Im terms of the above sald policy the Company has authorised the following officials whose contact details are given hereunder for determining the materiality of events: ‘eNe, | Name of Key Managerial Designation Phone No. and Email Personnel T Mr Mahendra G. Patel Managing Director $91-79-67778000 mgpatel@lincolnpharma.com z Mr. Bhavik . Parikh Company Secretary +91-79-67778081 es@lincolnpharma.com 3, The quarterly un-audited financial results for the quarter ended on 31+ December, 2015. A copy of the said quarterly un-audited financial results along with the Limited Review Report ofthe Auditors Is enclosed herewith The meeting of the Board of Directors ofthe Company commenced at 915 am, and concluded at 1000am Kindly acknowledge the receipt ofthe same. ‘Thanking you, Yours faithfully, FOR LINCOLN PHARMACEUTICALS LTD, ‘OR / AUTHORISED SIGNATORY) HowsgeScience City Road, Sola, Ahmedabad-380 060, Gujarat, India ingat +91-79-8777 8000 Fax: 91-79-6777 8082 fo@tincolnpharma.com | Website : www lincolnpharma.com Factory: 10,12, 13, Trim Estate, Near Khatraj Chokadi, P.O, Khatraj-382721. Ta, :Kalol Dist, Gandhinagar, (Gu Phone :02764-865000 | Fax :02764-281809 Email: khatrajalincolnpharma.com / Uincoln_Khatrajareitimai.comLINCOLN PHARMACEUTICALS LIMITED EEE ‘Statement of Consolidated and Standalone Unaudited Financial Results for the Quarter and Nine Months ended on 33/12/2015 saunes Taos] ovineJ. T. SHAH & CO CHARTER! CCOUNTANTS To Board of Directors of Lincoln Pharmaceuticals Limited Ahmedabad. We have reviewed the accompanying statement of unaudited financial results of Lincoln Pharmaceuticals Limited having its Registered Office at ‘Lincoln House", Science City Road, Sola, Ahmedabad-380060, for the quarter ended on 31/12/2015 except for the disclosures regarding Public Shareholding’ and ‘Promoter and Promoter Group Shareholding’ which have been traced from disclosures made by the management and have not been audited by us. This statement is the responsibility of the Company's Management and has been approved by the Board of Directors which has been prepared in accordance with applicable accounting standards specified under Section 133 of Companies Act, 2013 read with rule 7 of the Companies (Accounts) Rules, 2014) and other accounting policies generally accepted in India. Our responsibility is to issue a report on these financial statements based on our review. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2400, Engagements to Review Financial Statements issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable accounting standards specified under Section 133 of Companies Act, 2013 read with rule 7 of the Companies (Accounts) Rules, 2014) and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. For, J.T. Shah & Co. Chartered Accountants (FRN No. 109616W) Date: 11/02/2016 \ Place: Ahmedabad Sy eRe, Agit.Shah) artner [MNo.3983] 201/202, Lalita Comples, 352/3,Rasala Mag, Ne ain Temple, NNavrangpura, Ahmedabad 380008, Phone 264 444 20, 254 44a 30, 268-444 40,265 604 40